Ebpay官网

Good News | Shenzhen Cell Valley Honored as "Excellent Enterprise" in the China Innovation and Entrepreneurship Competition – Disruptive Technology Innovation Competition

Date:12-20  Hits:  Belong to:News

图片

The final round of the 13th China Innovation and Entrepreneurship Competition – Disruptive Technology Innovation Competition (Future Health Field) was successfully concluded in Fengxian District, Shanghai. The event was co-hosted by the Torch High-Technology Industry Development Center of the Ministry of Industry and Information Technology and the Fengxian District People's Government of Shanghai, and was organized by the Fengxian District Science and Technology Commission, the Nanqiao Town People's Government of Fengxian District, the State Key Laboratory of Bioreactor Engineering at East China University of Science and Technology, the Shanghai Hujiang Institute of Industrial Technology, and the China Technology Entrepreneurship Association.

图片

As an innovative enterprise in the future health field, Shenzhen Cell Valley adheres to the philosophy of "Cells benefit all, genes create the future" and is committed to the development of the cell and gene therapy industry. In this competition, Sun Rui, Head of the Marketing Department and Senior R&D Scientist, represented Shenzhen Cell Valley through an intense combination of roadshow presentations and defense sessions. Ultimately, Shenzhen Cell Valley was awarded the title of "Excellent Enterprise" in recognition of its leading position in retroviral vector technologies (including the PackRV-SS system) and its breakthrough achievements in both research and clinical applications.

This honor signifies that Shenzhen Cell Valley's professional capabilities and innovative accomplishments in the future health field have received high recognition and affirmation from the industry. At the same time, it serves as a great encouragement and inspiration for the company's future development. Shenzhen Cell Valley will continue to leverage its unique R&D capabilities and innovative spirit, persistently exploring and breaking new ground, to bring more hope and possibilities to the cause of human health.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@txtdh.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software